methylergonovine has been researched along with Heart Valve Diseases in 2 studies
*Heart Valve Diseases: Pathological conditions involving any of the various HEART VALVES and the associated structures (PAPILLARY MUSCLES and CHORDAE TENDINEAE). [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baumann, MH; Hufeisen, SJ; McBride, A; Rauser, L; Roth, BL; Rothman, RB; Savage, JE | 1 |
Golbraikh, A; Grulke, CM; Hajjo, R; Huang, XP; Roth, BL; Setola, V; Tropsha, A | 1 |
2 other study(ies) available for methylergonovine and Heart Valve Diseases
Article | Year |
---|---|
Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications.
Topics: Dose-Response Relationship, Drug; Ergotamine; Fenfluramine; Heart Valve Diseases; Humans; Methylergonovine; Norfenfluramine; Receptors, Serotonin; Serotonin Antagonists | 2000 |
Development, validation, and use of quantitative structure-activity relationship models of 5-hydroxytryptamine (2B) receptor ligands to identify novel receptor binders and putative valvulopathic compounds among common drugs.
Topics: Algorithms; Binding, Competitive; Databases, Factual; Dexfenfluramine; Drug-Related Side Effects and Adverse Reactions; Fenfluramine; Heart Valve Diseases; Ligands; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Radioligand Assay; Receptor, Serotonin, 5-HT2B; Serotonin 5-HT2 Receptor Agonists | 2010 |